Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01134354
Other study ID # TEFTOM EURASIA
Secondary ID
Status Completed
Phase N/A
First received May 28, 2010
Last updated June 18, 2014
Start date June 2010
Est. completion date February 2014

Study information

Verified date June 2014
Source AO Clinical Investigation and Documentation
Contact n/a
Is FDA regulated No
Health authority Switzerland: EthikkommissionAustria: EthikkommissionHong Kong: Ethics CommitteeChina: Ethics Committee
Study type Observational

Clinical Trial Summary

Design:

Prediction trial, up to 10 sites in Asia and Europe

Goal:

To better understand the "success" or "failure" after orthopedic trauma surgery by developing a model that can be applied clinically as a user-friendly "baseline" questionnaire - capable of predicting "success" or "failure" based on a patient's pre-surgical expectations of their final outcome and to validate a novel outcomes measure (TOM).

Primary aim:

To assess the psychometric properties of predictive validity, internal consistency and reproducibility of the trauma expectation factor (TEF) in the Eurasian population.

Secondary aim:

To assess the psychometric properties of criterion validity, internal consistency,reproducibility, and sensitivity to change of the TOM in the Eurasian population.

Key questions related to patient and surgeon expectations:

- How different, or similar, are patient and surgeon expectations?

- Do expectations change over time?

- Do patient expectations predict outcomes in validated measures use today?


Recruitment information / eligibility

Status Completed
Enrollment 199
Est. completion date February 2014
Est. primary completion date February 2014
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Isolated ankle or distal tibia fracture

- Scheduled for and undergoing one of the following surgeries for their fracture:

- Open fracture and internal fixation (ORIF)

- external fixation (EF)

- EF followed by ORIF

- 18 years of age or older

- Understand and read country national language at elementary level

- Able to understand the purpose of the clinical trial,

- Able and willing to conduct all follow-up visits

- Signed informed consent

Exclusion Criteria:

- Subject has previously undergone internal fixation surgery for this ankle/distal tibia fracture.

- Subject has disease entity, or condition that precludes likelihood of bony union (e.g., metastatic cancer, metabolic bone disease).

- Subject has severe dementia or other severe mental health problem that may preclude him/her from completing study questionnaires.

- Subject is participating in other competing clinical research that may interfere with participation in this research.

- Subject is unlikely to attend study related follow-up visits.

- Subject has poly-trauma (more than one organ system compromised)

- Subject has additional fracture(s) other than ankle fracture

- Subject is a prisoner

- Fracture occurred more than 28 days before surgery

Study Design

Time Perspective: Prospective


Locations

Country Name City State
China Queen Mary Hospital Hong Kong
China Shanghai Sixth People's Hospital Shanghai
Germany Universitätsklinikum Köln Köln
India HOSMAT Hospital Bangalore
Spain Hospital Universitari de Girona Doctor Josep Trueta Girona
Switzerland Kantonsspital Luzern Luzern
Switzerland Stadtspital Triemli Zürich

Sponsors (1)

Lead Sponsor Collaborator
AO Clinical Investigation and Documentation

Countries where clinical trial is conducted

China,  Germany,  India,  Spain,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Teftom Questionnaire one year No